Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Archiv Der Pharmazie
|
February 8, 2021
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors
Helmy Sakr, Rezk R Ayyad, Ali A El-Helby, et al.
RSC Advances
|
July 26, 2023
Design, synthesis, <i>in silico</i> studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
Abdulrahman M Saleh, Hazem A Mahdy, Mohamed Ayman El-Zahabi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 13, 2021
Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and <i>in vivo</i> studies
Mohamed M Khalifa, Ahmed A Al-Karmalawy, Eslam B Elkaeed, et al.
Bioorganic & Medicinal Chemistry
|
September 3, 2021
Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies
Nawaf A Alsaif, Mohammed S Taghour, Mohammed M Alanazi, et al.
Molecular Diversity
|
August 30, 2021
Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase
Nawaf A Alsaif, Alaa Elwan, Mohammed M Alanazi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 31, 2022
Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates <i>via</i> a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
Ibrahim H Eissa, Radwan El-Haggar, Mohammed A Dahab, et al.
Archiv Der Pharmazie
|
October 19, 2020
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors
Khaled El-Adl, Abdel-Ghany A El-Helby, Helmy Sakr, et al.
Future Medicinal Chemistry
|
May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approaches
Eslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.
Bioorganic Chemistry
|
March 15, 2021
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis
Nawaf A Alsaif, Mohammed A Dahab, Mohammed M Alanazi, et al.
Bioorganic Chemistry
|
May 8, 2021
Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents
Souad A El-Metwally, Mohsen M Abou-El-Regal, Ibrahim H Eissa, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Archiv Der Pharmazie
|
February 8, 2021
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors
Helmy Sakr, Rezk R Ayyad, Ali A El-Helby, et al.
RSC Advances
|
July 26, 2023
Design, synthesis, <i>in silico</i> studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
Abdulrahman M Saleh, Hazem A Mahdy, Mohamed Ayman El-Zahabi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 13, 2021
Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and <i>in vivo</i> studies
Mohamed M Khalifa, Ahmed A Al-Karmalawy, Eslam B Elkaeed, et al.
Bioorganic & Medicinal Chemistry
|
September 3, 2021
Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies
Nawaf A Alsaif, Mohammed S Taghour, Mohammed M Alanazi, et al.
Molecular Diversity
|
August 30, 2021
Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase
Nawaf A Alsaif, Alaa Elwan, Mohammed M Alanazi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
May 31, 2022
Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates <i>via</i> a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
Ibrahim H Eissa, Radwan El-Haggar, Mohammed A Dahab, et al.
Archiv Der Pharmazie
|
October 19, 2020
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors
Khaled El-Adl, Abdel-Ghany A El-Helby, Helmy Sakr, et al.
Future Medicinal Chemistry
|
May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approaches
Eslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.
Bioorganic Chemistry
|
March 15, 2021
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis
Nawaf A Alsaif, Mohammed A Dahab, Mohammed M Alanazi, et al.
Bioorganic Chemistry
|
May 8, 2021
Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents
Souad A El-Metwally, Mohsen M Abou-El-Regal, Ibrahim H Eissa, et al.
Page
of 5